📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Teneobio

1.1 - Company Overview

Teneobio Logo

Teneobio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of human heavy chain antibody discovery and development, with pre-clinical and clinical programs for multiple myeloma, prostate cancer, and immune disorders. Its antibody discovery engine is based on UniRat™.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Teneobio

Avalyn Pharma Logo

Avalyn Pharma

HQ: United States Website
  • Description: Provider of inhaled therapies for idiopathic pulmonary fibrosis and other respiratory diseases, advancing direct-lung delivery candidates including AP01 (Phase 2b-ready inhaled pirfenidone), AP02 (reformulated inhaled nintedanib; Phase 1a completed), AP02-DP (dry powder nintedanib with equivalent pulmonary bioavailability), AP03 (fixed-dose inhaled pirfenidone+nintedanib), and AP04 (inhaled imatinib for PAH).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avalyn Pharma company profile →
AMSBIO Logo

AMSBIO

HQ: United Kingdom Website
  • Description: Provider of life science technology products and services for R&D in medical, nutrition, cosmetics, and energy, including monoclonal, polyclonal, and secondary antibodies; GMP compliance support; FDA-aligned tissue arrays for immunohistochemistry; protein expression; transduction-ready lentivirus, adenovirus, and AAV; and peptide and antibody production services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AMSBIO company profile →
Vicam Logo

Vicam

HQ: United States Website
  • Description: Provider of testing solutions to detect mycotoxins in raw materials, grains, and feeds; aflatoxins in food and feed products; Bisphenol A (BPA) in consumer products; citrinin in food and feed; deoxynivalenol (DON) in grains and feeds; and fumonisins in corn, to prevent contamination, ensure safety, and comply with safety regulations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vicam company profile →
Pepscan Logo

Pepscan

HQ: The Netherlands Website
  • Description: Provider of peptide R&D and production services, employing protein mimicry techniques and patented technologies. Offerings include peptide libraries, CLIPS technology, personalized neoantigen peptide pools, epitope mapping, and custom peptide synthesis with modifications, plus phage display and lead optimization at an end-to-end facility in Lelystad, the Netherlands.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pepscan company profile →
CC Bio Logo

CC Bio

HQ: United Kingdom Website
  • Description: Provider of microbiome-focused therapeutic discovery for diagnosis and treatment. Products include Zeus, a platform to evaluate and optimize therapeutics for precise augmentation of microbial ecology; Athena, a platform developing genetic components for biosensor circuits that sense microbiome diseases; and Dionysus, a program engineering bacterial chassis to sense metabolic changes and record information across human tissues.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CC Bio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Teneobio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Teneobio

2.2 - Growth funds investing in similar companies to Teneobio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Teneobio

4.2 - Public trading comparable groups for Teneobio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Teneobio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Teneobio

What does Teneobio do?

Teneobio is a provider of human heavy chain antibody discovery and development, with pre-clinical and clinical programs for multiple myeloma, prostate cancer, and immune disorders. Its antibody discovery engine is based on UniRat™.

Who are Teneobio's competitors?

Teneobio's competitors and similar companies include Avalyn Pharma, AMSBIO, Vicam, Pepscan, and CC Bio.

Where is Teneobio headquartered?

Teneobio is headquartered in United States.

How many employees does Teneobio have?

Teneobio has 1,000 employees 🔒.

When was Teneobio founded?

Teneobio was founded in 2010 🔒.

What sector and industry vertical is Teneobio in?

Teneobio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Teneobio

Who are the top strategic acquirers in Teneobio's sector and industry

Top strategic M&A buyers and acquirers in Teneobio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Teneobio?

Top strategic M&A buyers groups and sectors for Teneobio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Teneobio's sector and industry vertical

Which are the top PE firms investing in Teneobio's sector and industry vertical?

Top PE firms investing in Teneobio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Teneobio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Teneobio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Teneobio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Teneobio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Teneobio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Teneobio?

The key public trading comparables and valuation benchmarks for Teneobio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Teneobio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Teneobio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Teneobio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Teneobio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Teneobio's' sector and industry vertical?

Access recent funding rounds and capital raises in Teneobio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Teneobio